 Teva Pharmaceutical was able to achieve a nationwide settlement to the opioid crisis, proving the ability of the companys management to overcome difficulties. Teva Pharmaceuticals provision for legal settlements and loss contingencies was 4,077 million in Q3 2022, up 103 year-over-year. 